The research-grade material supplied by Koi Peptides is synthesized independently for in vitro laboratory research only not formulated, packaged, or labeled for human use, not equivalent to or a substitute for any approved drug or cosmetic product, and not authorized for any human or veterinary indication
There is one new side effect, however, that was not seen in earlier Phase 2 trials
Reach out to your healthcare provider if you experience any of following: Anxiety that is persistent, worsening, or interfering with daily life Feelings of depression or hopelessness Suicidal thoughts or thoughts of self harm Panic attacks or severe episodes of nervousness Physical symptoms like rapid heartbeat, trembling, or dizziness that do not resolve with eating Bottom Line Anxiety is not a recognized side effect of tirzepatide based on current FDA labeling and major clinical trial data
By co-isolating the three MS 2 product ions prior to dissociation, more of the original precursor signal is measured at the MS 3 level